Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.

about

Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.

Item

http://www.wikidata.org/entity/Q52671150

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Cytokine-induced killer cells ...... the treatment of lung cancer.

@en

Cytokine-induced killer cells ...... the treatment of lung cancer.

@nl

type

Item

label

Cytokine-induced killer cells ...... the treatment of lung cancer.

@en

Cytokine-induced killer cells ...... the treatment of lung cancer.

@nl

prefLabel

Cytokine-induced killer cells ...... the treatment of lung cancer.

@en

Cytokine-induced killer cells ...... the treatment of lung cancer.

@nl

P1476

Cytokine-induced killer cells ...... the treatment of lung cancer.

@en

P2093

Changwen Jing

http://www.w3.org/2001/XMLSchema#string

Dan Chen

http://www.w3.org/2001/XMLSchema#string

Haixia Cao

http://www.w3.org/2001/XMLSchema#string

Huanhuan Sha

http://www.w3.org/2001/XMLSchema#string

Jianzhong Wu

http://www.w3.org/2001/XMLSchema#string

Jifeng Feng

http://www.w3.org/2001/XMLSchema#string

Junying Zhang

http://www.w3.org/2001/XMLSchema#string

Rong Ma

http://www.w3.org/2001/XMLSchema#string

Shuchen Dong

http://www.w3.org/2001/XMLSchema#string

Siwen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.

Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition

Potential role of immunotherapy in advanced non-small-cell lung cancer

CIK as therapeutic agents against tumors.

Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy.

A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.

PD-1 and PD-L1 antibodies in cancer: current status and future directions.

P304

366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41419-018-0404-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29511158

http://www.w3.org/2001/XMLSchema#string

P932

5840363

http://www.w3.org/2001/XMLSchema#string